Pacific Biosciences of California (PACB) support and resistance · rev $38.4M
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
This page maps Pacific Biosciences of California (PACB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
PACB currently screens at market cap $387.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PACB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PACB quote page for the session range and the stock page for the full model.
Not investment advice.